Retatrutide

Description

Overview

Retatrutide (also referred to as GLP-3 or LY3437943) is a synthetic peptide engineered as a triple agonist of the GLP-1, GIP, and glucagon receptors. It was developed as a research tool to investigate the combined activation of three incretin and metabolic-hormone pathways within a single molecule.

Research Background

Preclinical and early clinical research has examined Retatrutide as part of a class of multi-receptor incretin agonists, with studies focusing on energy balance, lipid and glucose metabolism, and adipose tissue regulation. Its triple-agonist profile distinguishes it from earlier dual-receptor peptides such as Tirzepatide.

Storage & Handling

Store lyophilized peptide at -20°C for long-term stability. Once reconstituted with bacteriostatic water, store at 2–8°C and use within recommended timeframes. Handle under sterile laboratory conditions and avoid repeated freeze-thaw cycles.

Disclaimer:
This product is for laboratory research use only. It is not intended for human or animal consumption or for use in any diagnostic, therapeutic, or clinical applications.